Pull to refresh
Logo
Daily Brief
Following
Why Ranks Sign Up
Caribou Biosciences

Caribou Biosciences

Biotechnology Company

Appears in 1 story

Stories

Off-the-shelf cancer cell therapy clears major regulatory hurdle toward replacing custom-made treatments

New Capabilities

Developer of CB-011; advancing through accelerated FDA pathway

Every approved cancer cell therapy today requires extracting a patient's own cells, engineering them in a lab, and infusing them back. It costs over $400,000 and sometimes takes weeks — long enough that patients' cancer can grow while they wait.

Updated May 30